Show simple item record

dc.contributor.authorChandrasekaran, Den_US
dc.contributor.authorManchanda, Ren_US
dc.date.accessioned2018-04-30T10:56:48Z
dc.date.available2018-03-19en_US
dc.date.issued2018-10en_US
dc.date.submitted2018-03-29T04:13:37.855Z
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/36592
dc.format.extent1460 - ?en_US
dc.languageengen_US
dc.relation.ispartofBJOGen_US
dc.rightsThis article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1111/1471-0528.15225 This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.
dc.titleGermline and somatic genetic testing in ovarian cancer patients.en_US
dc.typeArticle
dc.rights.holderThis article is protected by copyright. All rights reserved.
dc.identifier.doi10.1111/1471-0528.15225en_US
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/29577554en_US
pubs.issue11en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume125en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record